Core Insights - Milestone Scientific Inc. reported continued progress in operational transformation and growth strategy across its dental and medical segments, with a focus on building a leaner organization for sustained growth and improved profitability [1][2]. Financial Performance - For Q3 2025, revenues were approximately $2.4 million, a slight decrease from $2.5 million in Q3 2024, primarily due to lower domestic dental sales, partially offset by higher international dental sales and recurring medical revenue [3]. - Gross profit for Q3 2025 was approximately $1.6 million, or 70% of revenue, compared to $1.8 million, or 73% of revenue, in Q3 2024 [3]. - The operating loss for Q3 2025 was approximately $(1.1) million, an improvement of approximately $0.3 million, or 23%, from $(1.5) million in Q3 2024, attributed to lower selling, general, and administrative expenses [3]. - The net loss for Q3 2025 was approximately $(1.2) million, or $(0.01) per share, compared to a net loss of $(1.5) million, or $(0.02) per share, in Q3 2024 [3]. Year-to-Date Results - For the nine months ended September 30, 2025, revenues were approximately $6.9 million, an increase of approximately $0.3 million, or 5%, from $6.6 million in the same period of 2024, driven by growth in international dental sales and higher recurring revenue from the medical segment [4]. - Gross profit for the nine months ended September 30, 2025, was approximately $4.9 million, or 71% of revenue, consistent with the previous year [4]. - The operating loss for the nine months ended September 30, 2025, was approximately $(4.6) million, slightly improved from $(4.7) million in the same period of 2024 [4]. - The net loss for the nine months ended September 30, 2025, was approximately $(4.6) million, or $(0.06) per share, compared to a net loss of $(2.7) million, or $(0.03) per share, in the same period of 2024 [4]. Cash Position - As of September 30, 2025, the company reported cash and cash equivalents of approximately $1.3 million and working capital of approximately $3.1 million [5]. Strategic Initiatives - The company is expanding its direct sales programs in North America and securing new international registrations for its STA® Single Tooth Anesthesia System, while enhancing its omnichannel digital marketing strategy [2]. - There is growing utilization and recurring revenue from CompuFlo® disposables, with increasing interest from hospitals and international distributors [2]. - The company is advancing its reimbursement strategy for CompuFlo®, focusing on securing Medicare payment-rate assignments and expanding commercial coverage, which are seen as key enablers for broader adoption [2].

Core Insights - Milestone Scientific Inc. is undergoing a transformation aimed at strengthening its dental and medical businesses, reducing operating expenses, and positioning the company for accelerated growth and improved financial performance [1] Business Strategy - The new CEO, Eric Hines, has conducted a comprehensive review of operations and implemented strategic actions to accelerate growth, strengthen competitive position, and improve operating efficiency [2] - In the dental segment, the company is expanding North American sales programs, focusing on direct sales, enhancing omnichannel digital marketing, and securing new international registrations for the STA® Single Tooth Anesthesia System [2] - A similar strategy will be applied to the medical segment, including a guided relaunch of CompuFlo® and investment in market analysis and reimbursement strategies to maximize its commercial potential [2] Financial Performance - In the third quarter, the company reduced operating expenses by approximately 20% compared to the same period in 2024 while achieving modest revenue growth and an increase in recurring revenue from CompuFlo disposables [3] - There is strong international interest in CompuFlo, indicating potential for future growth [3] Future Outlook - The company is committed to advancing its innovative technology, expanding market presence, and executing on new products and partnerships [3] - The steps being taken are expected to provide a strong foundation for sustained growth and profitability [3]